Clinical trials
Trials in Australia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
567 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 14 |
| 2005 | 25 |
| 2006 | 16 |
| 2007 | 23 |
| 2008 | 16 |
| 2009 | 14 |
| 2010 | 18 |
| 2011 | 20 |
| 2012 | 21 |
| 2013 | 24 |
| 2014 | 20 |
| 2015 | 21 |
| 2016 | 17 |
| 2017 | 37 |
| 2018 | 37 |
| 2019 | 30 |
| 2020 | 40 |
| 2021 | 45 |
| 2022 | 48 |
| 2023 | 36 |
| 2024 | 16 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 567 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayside Health | 39 |
| University of Sydney | 20 |
| The University of Queensland | 15 |
| Peter MacCallum Cancer Centre, Australia | 14 |
| The University of New South Wales | 14 |
| Austin Health | 11 |
| University of Adelaide | 9 |
| University of Melbourne | 9 |
| Kirby Institute | 8 |
| Melbourne Health | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 18 |
| Breast Neoplasms | 15 |
| Neoplasms | 15 |
| Melanoma | 13 |
| Colorectal Neoplasms | 12 |
| Heart Failure | 12 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Hepatitis C | 11 |
| Coronary Artery Disease | 10 |
| Neoplasm Metastasis | 10 |
Trials
Showing 1 to 25 of 567. Each trial links to its page on Pharma Observatory.
467 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.